Literature DB >> 26427665

The emerging role of Nemo-like kinase (NLK) in the regulation of cancers.

Ying Huang1,2,3, Yang Yang1,2, Yong He1,2, Jun Li4,5.   

Abstract

Nemo-like kinase (NLK) is an evolutionarily conserved mitogen-activated protein (MAP) kinase-related kinase that is highly expressed in neural tissues and minimally detected in others. Accumulating evidence demonstrates that NLK exerts a pivotal role in cell proliferation, migration, invasion, and apoptosis via regulation of a variety of transcriptional molecules. The results of recent studies have shown that aberrant expression of NLK is significantly associated with the initiation and progression of various types of human cancers, as well as clinicopathologic features and survival rate. NLK is gradually considered as a potential tumor suppressor or an oncogene depending on the tumor system, and silencing or upregulating of NLK may provide an effective therapeutic approach against tumors. In this review, we will make a summary on the comprehensive roles of NLK in the regulation of various cancers.

Entities:  

Keywords:  Cancer; Nemo-like kinase; Non-coding RNA; Wnt

Mesh:

Substances:

Year:  2015        PMID: 26427665     DOI: 10.1007/s13277-015-4159-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  43 in total

Review 1.  The pivotal role of microRNA-155 in the control of cancer.

Authors:  Zhaolin Chen; Taotao Ma; Cheng Huang; Tingting Hu; Jun Li
Journal:  J Cell Physiol       Date:  2014-05       Impact factor: 6.384

2.  Rotation of photoreceptor clusters in the developing Drosophila eye requires the nemo gene.

Authors:  K W Choi; S Benzer
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

3.  miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase.

Authors:  Kun Wang; Xuan Wang; Jian Zou; Anling Zhang; Yingfeng Wan; Peiyu Pu; Zhengfei Song; Cong Qian; Yili Chen; Shuxu Yang; Yirong Wang
Journal:  Neuro Oncol       Date:  2013-02-14       Impact factor: 12.300

4.  Nlk is a murine protein kinase related to Erk/MAP kinases and localized in the nucleus.

Authors:  B K Brott; B A Pinsky; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

Review 5.  Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.

Authors:  Naoko Takebe; Pamela J Harris; Ronald Q Warren; S Percy Ivy
Journal:  Nat Rev Clin Oncol       Date:  2010-12-14       Impact factor: 66.675

6.  Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma.

Authors:  Kwang Hwa Jung; Jeong Kyu Kim; Ji Heon Noh; Jung Woo Eun; Hyun Jin Bae; Hong Jian Xie; Young Min Ahn; Won Sang Park; Jung Young Lee; Suk Woo Nam
Journal:  J Cell Biochem       Date:  2010-06-01       Impact factor: 4.429

7.  Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells.

Authors:  Katayoon H Emami; Lisha G Brown; Tiffany E M Pitts; Xizhang Sun; Robert L Vessella; Eva Corey
Journal:  Prostate       Date:  2009-10-01       Impact factor: 4.104

8.  Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling.

Authors:  Tohru Ishitani; Jun Ninomiya-Tsuji; Kunihiro Matsumoto
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

9.  nemo-like kinase is an essential co-activator of Wnt signaling during early zebrafish development.

Authors:  Chris J Thorpe; Randall T Moon
Journal:  Development       Date:  2004-05-19       Impact factor: 6.868

10.  Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer.

Authors:  Zhi-Yuan Xu; Qi-Ming Yu; Yi-An Du; Li-Tao Yang; Rui-Zeng Dong; Ling Huang; Peng-Fei Yu; Xiang-Dong Cheng
Journal:  Int J Biol Sci       Date:  2013-06-28       Impact factor: 6.580

View more
  4 in total

1.  YAP needs Nemo to guide a Hippo.

Authors:  Alexander Hergovich
Journal:  EMBO Rep       Date:  2016-12-15       Impact factor: 8.807

2.  Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer.

Authors:  Xian Wang; Jamunarani Veeraraghavan; Chia-Chia Liu; Xixi Cao; Lanfang Qin; Jin-Ah Kim; Ying Tan; Suet Kee Loo; Yiheng Hu; Ling Lin; Sanghoon Lee; Martin J Shea; Tamika Mitchell; Shunqiang Li; Matthew J Ellis; Susan G Hilsenbeck; Rachel Schiff; Xiao-Song Wang
Journal:  Clin Cancer Res       Date:  2021-02-04       Impact factor: 12.531

Review 3.  Nemo-Like Kinase in Development and Diseases: Insights from Mouse Studies.

Authors:  Renée Daams; Ramin Massoumi
Journal:  Int J Mol Sci       Date:  2020-12-02       Impact factor: 5.923

4.  NLK interacts with 14‑3‑3ζ to restore the expression of E‑cadherin.

Authors:  Jie Chen; Qingfeng Lin; Tingting Ni; Jiyi Zhao; Feng Lin; Xiangdong Lu; Ye Lv; Shujuan Ren; Zhili Liu; Ting Zhang; Shuyan He; Dong Shen; Weidong Mao
Journal:  Oncol Rep       Date:  2020-03-20       Impact factor: 3.906

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.